Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Fetal environments contain various chemicals that may disrupt hormones.

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

DHEA may play a complex role in PCOS, affecting hormones, metabolism, and symptoms.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

DMSO-liposomes improve finasteride delivery for hair loss treatment.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Monitoring steroid hormones in blood can better detect testosterone doping.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Some dibenzo compounds might help treat cancer with fewer side effects.

Transethosomes improve drug delivery through the skin by overcoming the outer skin layer's barrier.

Cyclosporin and minoxidil promote hair growth.

The method effectively identifies and measures seven banned substances in cosmetics.